Astrazeneca (AZN) Ascends But Remains Behind Market: Some Facts to NoteZacks Investment Research • 09/21/26
AZN's Klygefa Gets CHMP Nod for Generalised Myasthenia Gravis in EUZacks Investment Research • 09/21/26
FDA Grants Priority Review to AZN's Filing for Rare Bone Disease DrugZacks Investment Research • 09/18/26
Is It Worth Investing in Astrazeneca (AZN) Based on Wall Street's Bullish Views?Zacks Investment Research • 09/16/26
AZN's Etcamah Fails Late-Stage Study for First-line Breast CancerZacks Investment Research • 09/14/26
Susan G. Komen® and AstraZeneca Partnership to Make Patient Navigation Available to AllBusiness Wire • 09/14/26
AstraZeneca PLC (AZN) Presents at European Respiratory Society (ERS) Congress TranscriptSeeking Alpha • 09/08/26
Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%24/7 Wall Street • 09/08/26